Deprescribing Psychiatric Medications in Youth: A Feasibility Study
Community Mental Health Journal · 29.07.2026
DOI: 10.1007/s10597-026-01697-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Community Mental Health Journal, online erschienen am 29.07.2026. Verfasst von Erin R Barnett und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Geisel School of Medicine at Dartmouth, Dartmouth Health, Hanover, NH, USA. erin.r.barnett@dartmouth.edu. Die Arbeit nennt 78 Literaturangaben. Gefördert von: The Charles H. Hood Foundation, Inc..
Abstract (Originalsprache)
Rates of psychiatric medications prescribed to U.S. youth have increased substantially and stakeholders are increasingly concerned. We tested the feasibility of a novel intervention that combines shared decision making and a structured deprescribing protocol during routine outpatient care with youth. Five clinicians delivered the intervention to youth 6 to 17 years old receiving three or more psychiatric medications or an off-label antipsychotic. Families completed assessments at baseline, 18- and 30-weeks. We collected data via surveys, medical records, and qualitative interviews. We enrolled 31 youth, 29 received the intervention, and 13 of the 29 (45%) chose to deprescribe. Eleven of those 13 reduced their dose or stopped completely; 2 returned to their original dose. Of the 13 that agreed to deprescribe, the mean dose-weighted medication use reduced from 3.9 (SD=1.38) to 2.9 (SD=1.41), and the mean number of medication reactions reduced from 1.3 (SD=2.21) to 0.3 (SD=0.48). In the 16 participants who chose not to deprescribe, the mean dose-weighted medication use and medication reactions reduced from 3.4 (SD=0.89) to 3.2 (SD=1.32) and 0.6 (SD=0.89) to 0.0 (SD=0.0), respectively. Youth functioning remained similar across groups. There were no study-related serious adverse events. Clinicians and caregivers considered the intervention feasible, valuable, and effective. Our intervention and procedures were feasible in real-world community settings. The intervention shows promising findings related to safety and effectiveness. Trial registration: Our study was retrospectively registered with ClinicalTrials.gov. NCT # pending.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Geisel School of Medicine at Dartmouth, Dartmouth Health, Hanover, NH, USA. erin.r.barnett@dartmouth.edu.
- The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA. erin.r.barnett@dartmouth.edu.
- Department of Psychiatry, Geisel School of Medicine at Dartmouth, Dartmouth Health, Hanover, NH, USA.
- The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA.
- Cayuga County Community Mental Health Center, Auburn, NY, USA.
- Clinton County Mental Health Services, Plattsburgh, NY, USA.
Förderung
- The Charles H. Hood Foundation, Inc.
Zitieren
APA
Barnett, E. R., McLaren, J. L., Leavitt, H. B., Acquilano, S. C., Bazeghi, R., Bizzari, S., Garami, A., King, J., Fehnert, B., & Elwyn, G. (2026). Deprescribing Psychiatric Medications in Youth: A Feasibility Study. Community Mental Health Journal. https://doi.org/10.1007/s10597-026-01697-4
Vancouver
Barnett ER, McLaren JL, Leavitt HB, Acquilano SC, Bazeghi R, Bizzari S, et al. Deprescribing Psychiatric Medications in Youth: A Feasibility Study. Community Mental Health Journal. 2026. doi:10.1007/s10597-026-01697-4
BibTeX
@article{Barnett2026,
author = {Barnett, Erin R and McLaren, Jennifer L and Leavitt, Hannah B and Acquilano, Stephanie C and Bazeghi, Rosemina and Bizzari, Stephanie and Garami, Anthony and King, James and Fehnert, Ben and Elwyn, Glyn},
title = {Deprescribing Psychiatric Medications in Youth: A Feasibility Study},
journal = {Community Mental Health Journal},
year = {2026},
doi = {10.1007/s10597-026-01697-4}
}
EUVIMED